Lyell Immunopharma, Inc. Quarterly Other Liabilities, Noncurrent in USD from Q4 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Lyell Immunopharma, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2020 to Q2 2025.
  • Lyell Immunopharma, Inc. Other Liabilities, Noncurrent for the quarter ending June 30, 2025 was $3.03M, a 11.9% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $3.03M -$409K -11.9% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $3.14M -$410K -11.5% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $3.25M -$411K -11.2% Dec 31, 2024 10-Q 2025-08-12
Q3 2024 $3.57M -$211K -5.59% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.44M -$449K -11.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.55M -$450K -11.2% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $3.66M -$449K -10.9% Dec 31, 2023 10-K 2025-03-11
Q3 2023 $3.78M -$451K -10.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.89M -$452K -10.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $4M -$452K -10.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.11M -$453K -9.92% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $4.23M -$785K -15.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $4.34M +$3.44M +382% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $4.45M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $4.57M +$4.03M +758% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $5.01M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $900K Jun 30, 2021 10-Q 2021-08-12
Q4 2020 $532K Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.